Target intelligence / Profile preview

MMEL1 antisense RNA 1 (MMEL1-AS1)

Target: MMEL1-AS1
Molecular classification: Antisense non-coding RNA

Overview

MMEL1 antisense RNA 1 (MMEL1-AS1) is an uncharacterized non-coding antisense RNA transcript associated with the MMEL1 gene locus. It is distinct from the protein-coding MMEL1 gene, which encodes a membrane metalloendopeptidase involved in peptide degradation and has relevance in pain perception, testis function, and immune-related disorders[2][3][5][7][8]. There is no evidence that MMEL1-AS1 has established roles in physiology, disease, or as a drug target. Most published research, biological databases, and therapeutic literature refer to MMEL1, not MMEL1-AS1. If you are seeking a validated therapeutic target at this locus, refer to membrane metallo-endopeptidase-like 1 (MMEL1), not MMEL1 antisense RNA 1.

Other names: MMEL1-AS1MMEL1 antisense RNA 1

Beyond the preview

Go deeper on MMEL1 antisense RNA 1 (MMEL1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MMEL1 antisense RNA 1 (MMEL1-AS1).

Explore the full profile